Proterra Inc. PTRAQ
—
- Market cap
- —
- P/E
- 0.0×
Follow PTRAQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '22 | Mar '23 | Jun '23 | Sep '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.10 | 0.10 | 0.10 | 0.03 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.45) | (0.45) | (0.45) | (0.16) | |
P/B ratio |
0.13 | 0.13 | 0.13 | 0.04 | |
Price to Tangible BV |
0.13 | 0.13 | 0.13 | 0.04 | |
EV/Sales |
0.29 | 0.29 | 0.29 | 0.46 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.40) | (0.40) | (0.40) | (0.63) | |
EV/FCF |
(0.34) | (0.34) | (0.34) | (0.55) | |
Quick Ratio |
1.76 | 0.86 | 0.68 | 1.09 | |
Current Ratio |
2.65 | 1.39 | 1.39 | 2.48 | |
Net Debt/EBITDA |
2.90 | 2.60 | 0.96 | (0.41) | |
Debt/Assets |
14.60% | 21.40% | 21.97% | 25.16% | |
Debt/Equity |
0.24 | 0.66 | 0.68 | 0.65 | |
Asset Turnover |
0.34 | 0.37 | 0.39 | 0.42 | |
Operating CF/Net income |
1.22 | (0.03) | 2.45 | (13.48) | |
Capex/Depreciation |
(2.02) | (0.81) | (0.12) | (1.83) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
23.47% | 23.29% | 17.41% | 12.76% | |
Selling, General and Administrative Expense of Revenue |
43.21% | 45.12% | 41.49% | 43.44% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
6.91% | 5.42% | 5.14% | 5.20% | |
Graham Net Nets |
2.59 | 2.59 | 2.59 | 9.02 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1,246.67%) | (1,246.67%) | (1,246.67%) | (3,120.00%) | |
Free Cash Flow Yield |
(851.00%) | (851.00%) | (851.00%) | (2,390.91%) | |
Revenue per Share |
0.36 | 0.35 | 0.38 | 0.38 | |
Operating CF per Share |
(0.44) | 0.03 | (0.33) | (0.31) | |
Capex per Share |
(0.08) | (0.04) | 0.00 | (0.03) | |
Free Cash Flow per Share |
(0.52) | (0.01) | (0.34) | (0.34) | |
Cash per Share |
1.38 | 1.36 | 1.03 | 0.69 | |
Shareholders Equity per Share |
2.30 | 1.20 | 1.17 | 1.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.30 | 1.20 | 1.17 | 1.21 | |
Free Cash Flow |
(116.66) | (1.34) | (76.97) | (77.43) | |
Working Capital |
414.76 | 182.14 | 180.29 | 321.49 | |
Capital Expenditures |
(17.64) | (8.45) | (0.92) | (7.11) | |
Net Current Asset Value |
342.12 | 94.37 | 88.38 | 102.75 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.22 | 0.11 | 0.01 | 0.08 | |
Net Profit Margin |
(101.24%) | (306.78%) | (36.16%) | 6.05% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
105.99 | 88.54 | 82.29 | 91.61 | |
Average Payables |
55.61 | 73.87 | 97.57 | 38.66 | |
Average Inventory |
142.06 | 166.94 | 220.65 | 214.22 | |
Average Assets |
911.17 | 883.83 | 869.44 | 798.16 | |
Average Common Equity |
618.51 | 472.81 | 455.97 | 431.85 |
Columns are period end dates